BBCR and its consultants are dedicated to advancing innovative and repurposed treatments for orphan diseases, an area where impact is high, but the path is complex.

BBCR and its consultants are dedicated to advancing innovative and repurposed treatments for orphan diseases—an area where impact is high, but the path is complex.

With limited patient populations and often little precedent, developing therapies in this space requires strategic precision. From building a compelling orphan drug petition to aligning on a viable clinical plan with the FDA, expert guidance is critical to overcoming scientific, regulatory, and operational challenges.

Our team brings deep expertise across biologics, cell and gene therapies, and small molecule development to help sponsors identify viable opportunities and bring treatments to underserved populations. We deliver end-to-end supportt – combining regulatory strategy, translational medicine, and clinical research execution – to streamline development and position programs for accelerated approval. With BBCR, you gain a partner focused on turning complex pathways into actionable progress.

Learn more about our innovation in Early Clinical Research and our Rare Disease Experience

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

Instagram

This field is for validation purposes and should be left unchanged.

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA